These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Anti-cocaine catalytic antibodies--a novel approach to the problem of addiction. Landry DW; Yang GX J Addict Dis; 1997; 16(3):1-17. PubMed ID: 9243335 [TBL] [Abstract][Full Text] [Related]
6. Application of artificial enzymes to the problem of cocaine. De Prada P; Winger G; Landry DW Ann N Y Acad Sci; 2000; 909():159-69. PubMed ID: 10911929 [TBL] [Abstract][Full Text] [Related]
7. Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10. Larsen NA; de Prada P; Deng SX; Mittal A; Braskett M; Zhu X; Wilson IA; Landry DW Biochemistry; 2004 Jun; 43(25):8067-76. PubMed ID: 15209502 [TBL] [Abstract][Full Text] [Related]
8. Antibody-catalyzed degradation of cocaine. Landry DW; Zhao K; Yang GX; Glickman M; Georgiadis TM Science; 1993 Mar; 259(5103):1899-901. PubMed ID: 8456315 [TBL] [Abstract][Full Text] [Related]
9. Cocaine esterase prevents cocaine-induced toxicity and the ongoing intravenous self-administration of cocaine in rats. Collins GT; Brim RL; Narasimhan D; Ko MC; Sunahara RK; Zhan CG; Woods JH J Pharmacol Exp Ther; 2009 Nov; 331(2):445-55. PubMed ID: 19710369 [TBL] [Abstract][Full Text] [Related]
10. Anticocaine catalytic antibodies have no affinity for RTI compounds: implications for treatment. Kuhar MJ; Carroll FI; Bharat N; Landry DW Synapse; 2001 Aug; 41(2):176-8. PubMed ID: 11400184 [TBL] [Abstract][Full Text] [Related]
12. Catalytic antibodies that hydrolyze (-)-cocaine obtained by a high-throughput procedure. Cashman JR; Berkman CE; Underiner GE J Pharmacol Exp Ther; 2000 Jun; 293(3):952-61. PubMed ID: 10869397 [TBL] [Abstract][Full Text] [Related]
13. Effects of a long-acting mutant bacterial cocaine esterase on acute cocaine toxicity in rats. Collins GT; Zaks ME; Cunningham AR; St Clair C; Nichols J; Narasimhan D; Ko MC; Sunahara RK; Woods JH Drug Alcohol Depend; 2011 Nov; 118(2-3):158-65. PubMed ID: 21481548 [TBL] [Abstract][Full Text] [Related]
14. Cocaine catalytic antibodies: the primary importance of linker effects. Matsushita M; Hoffman TZ; Ashley JA; Zhou B; Wirsching P; Janda KD Bioorg Med Chem Lett; 2001 Jan; 11(2):87-90. PubMed ID: 11206477 [TBL] [Abstract][Full Text] [Related]
15. Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Xi ZX; Yang Z; Li SJ; Li X; Dillon C; Peng XQ; Spiller K; Gardner EL Neuropharmacology; 2007 Nov; 53(6):771-82. PubMed ID: 17888459 [TBL] [Abstract][Full Text] [Related]
16. Effects of remoxipride, an atypical antipsychotic, on cocaine self-administration in the rat using fixed- and progressive-ratio schedules of reinforcement. Bourland JA; French ED Drug Alcohol Depend; 1995 Dec; 40(2):111-4. PubMed ID: 8745132 [TBL] [Abstract][Full Text] [Related]
17. Long-lasting effects of a PEGylated mutant cocaine esterase (CocE) on the reinforcing and discriminative stimulus effects of cocaine in rats. Collins GT; Narasimhan D; Cunningham AR; Zaks ME; Nichols J; Ko MC; Sunahara RK; Woods JH Neuropsychopharmacology; 2012 Apr; 37(5):1092-103. PubMed ID: 21993206 [TBL] [Abstract][Full Text] [Related]
18. WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation. Vlachou S; Nomikos GG; Panagis G Behav Brain Res; 2003 May; 141(2):215-22. PubMed ID: 12742258 [TBL] [Abstract][Full Text] [Related]